Closing rural diagnostic gap, HealthTrackRx delivers next-morning PCR test results nationwide to improve infection diagnosis and treatment.
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the ...
Medical Device Network on MSN
Co-Dx to form JV with Arabian Eagle for PCR platform distribution
Co-Dx has signed a definitive agreement with Arabian Eagle Manufacturing to create a joint venture (JV) for PCR platform ...
Nirsevimab continued to provide strong protection against respiratory syncytial virus-associated bronchiolitis in paediatric ...
In a fast-changing world that is learning to live with climate change, industrial farming and evolving ecosystems, food safety has become a critical concern for both producers and consumers. Seqlo by ...
On Oct. 27, a 22-year-old draft gelding in Oakland County, Michigan, tested positive for strangles. Another horse at the ...
From the healthcare field, Monere Corp. wants to work on expanding its footprint in India for an innovative and ...
The UK Food Safety Testing market is growing due to increasing consumer awareness, regulatory standards, and demand for contamination-free food. Opportunities include the rise in rapid and real-time ...
On Oct. 28, a 14-year-old gelding in Pasco County, Florida, tested positive for strangles. The horse developed clinical signs on Oct. 23, including nasal discharge and a draining lymph node abscess.
A customer of a former Labour minister’s allegedly fraudulent Covid-19 testing firm told a court the company offered her a ...
Medical Device Network on MSN
Roche secures CE mark for acute dengue virus infection diagnostic test
Roche has obtained CE mark approval for its fully automated immunoassay, Elecsys Dengue Ag test, intended for diagnosing ...
News Medical on MSN
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement To Develop Droplet Digital™ PCR High Complexity Assays
Biodesix expands its Bio-Rad partnership to validate ddPCR cancer assays, starting with ESR1 mutation testing in breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results